A fascinating association between HDL as a multi-potent particle and hypertension

Hayato Tada,Masayuki Takamura

DOI: https://doi.org/10.1038/s41440-024-01633-7

2024-03-15

Hypertension Research

Abstract:Hypertension Research, Published online: 14 March 2024; doi:10.1038/s41440-024-01633-7 A fascinating association between HDL as a multi-potent particle and hypertension

peripheral vascular disease

What problem does this paper attempt to address?

Intriguing review and topics in this month of Hypertension Research

Satoshi Hoshide,Masaki Mogi,Kazuomi Kario

DOI: https://doi.org/10.1038/s41440-023-01532-3

2024-02-06

Hypertension Research

Abstract:Hypertension Research, Published online: 05 February 2024; doi:10.1038/s41440-023-01532-3 Intriguing review and topics in this month of Hypertension Research

peripheral vascular disease
The causal relationship between non-alcoholic fatty liver disease, hypertension, and cardiovascular diseases: implications for future research

Toshiki Maeda

DOI: https://doi.org/10.1038/s41440-024-01759-8

2024-06-20

Hypertension Research

Abstract:Hypertension Research, Published online: 19 June 2024; doi:10.1038/s41440-024-01759-8 The causal relationship between non-alcoholic fatty liver disease, hypertension, and cardiovascular diseases: implications for future research

peripheral vascular disease
Sex and age difference in associations between anthropometric indices and hypertension

Yukako Tatsumi

DOI: https://doi.org/10.1038/s41440-024-01630-w

2024-03-12

Hypertension Research

Abstract:Hypertension Research, Published online: 11 March 2024; doi:10.1038/s41440-024-01630-w Sex and age difference in associations between anthropometric indices and hypertension

peripheral vascular disease
Pulse pressure amplification as a hemodynamic predictor of cardiovascular disease

Junichiro Hashimoto

DOI: https://doi.org/10.1038/s41440-024-01880-8

2024-09-11

Hypertension Research

Abstract:Hypertension Research, Published online: 11 September 2024; doi:10.1038/s41440-024-01880-8 Pulse pressure amplification as a hemodynamic predictor of cardiovascular disease

peripheral vascular disease
Bridging the Gap Between the Bench and Bedside: Clinical Applications of High-density Lipoprotein Function

Yasuhiro Endo,Kei Sasaki,Katsunori Ikewaki

DOI: https://doi.org/10.5551/jat.RV22020

2024-09-01

Abstract:Decades of research have reshaped our understanding of high-density lipoprotein (HDL) , shifting our focus from cholesterol (C) levels to multifaceted functionalities. Epidemiological studies initially suggested an association between HDL-C levels and cardiovascular disease (CVD) risk; however, such a simple association has not been indicated by recent studies. Notably, genome-wide studies have highlighted discrepancies between HDL-C levels and CVD outcomes, urging a deeper exploration of the role of HDL. The key to this shift lies in elucidating the role of HDL in reverse cholesterol transport (RCT), which is a fundamental anti-atherosclerotic mechanism. Understanding RCT has led to the identification of therapeutic targets and novel interventions for atherosclerosis. However, clinical trials have underscored the limitations of HDL-C as a therapeutic target, prompting the re-evaluation of the role of HDL in disease prevention. Further investigations have revealed the involvement of HDL composition in various diseases other than CVD, including chronic kidney disease, Alzheimer's disease, and autoimmune diseases. The anti-inflammatory, antioxidative, and anti-infectious properties of HDL have emerged as crucial aspects of its protective function, opening new avenues for novel biomarkers and therapeutic targets. Omics technologies have provided insights into the diverse composition of HDL, revealing disease-specific alterations in the HDL proteome and lipidome. In addition, combining cell-based and cell-free assays has facilitated the evaluation of the HDL functionality across diverse populations, offering the potential for personalized medicine. Overall, a comprehensive understanding of HDL multifunctionality leads to promising prospects for future clinical applications and therapeutic developments, extending beyond cardiovascular health.
Original article and review highlighted in this month of Hypertension Research

Satoshi Hoshide,Masaki Mogi,Kazuomi Kario

DOI: https://doi.org/10.1038/s41440-024-01646-2

2024-05-07

Hypertension Research

Abstract:Hypertension Research, Published online: 07 May 2024; doi:10.1038/s41440-024-01646-2 Original article and review highlighted in this month of Hypertension Research

peripheral vascular disease
Combining muscle strengthening activity and aerobic exercise: a prescription for better health in patients with hypertension

Tatsuya Maruhashi,Yukihito Higashi

DOI: https://doi.org/10.1038/s41440-024-01868-4

2024-09-11

Hypertension Research

Abstract:Hypertension Research, Published online: 11 September 2024; doi:10.1038/s41440-024-01868-4 Combining muscle strengthening activity and aerobic exercise: a prescription for better health in patients with hypertension

peripheral vascular disease
Inverse Association of Serum Docosahexaenoic Acid With Newly Diagnosed Hypertension: A Community-based Case-control Study.

Bo Yang,Fang Ding,Feng-Lei Wang,Wei Yu,Duo Li

DOI: https://doi.org/10.1097/MD.0000000000002329

IF: 1.6

2016-01-01

Medicine

Abstract:Observational studies on circulating fatty acid (FA) and primary prevention of hypertension have yielded inconsistent results, and the association among the Chinese population is not fully clear. The aim of the study was to discern important FAs that can discriminate hypertensive patients from normotensive persons, and investigate associations between the important FAs and risk of hypertension.We conducted a case-control study nested within a community-based cohort of 2447 Chinese participants aged 35 to 79 years who completed a baseline assessment between October 2012 and April 2013. In all, 480 patients with newly diagnosed hypertension were identified at baseline and 480 normotensive individuals were randomly selected as matched normotensive controls. Controls were individually matched to cases by age (±2 y), sex, and recruitment center, with a 1:1 case-to-control ratio. Serum FA profile was compared between cases and controls by orthogonal partial least squares-discriminant analyses. Odds ratio (OR) with 95% confidence interval (CI) for newly diagnosed hypertension was estimated by a conditional logistical analysis.After adjustment for body mass index, education, profession, family history of hypertension, salt intake, heart rate, blood lipids, and fasting glucose levels, serum FA profile in hypertensive patients was typically characterized by higher 16:0 and 16:1n-7, and lower 18:2n-6 and 22:6n-3, compared with normotensive controls. Docosahexaenoic acid (22:6n-3) and palmitoleic acid (16:1n-7) were identified as the important FA contributing most to the intergroup separations. When comparing the highest and lowest quartile of FA composition, newly diagnosed hypertension was negatively associated with 22:6n-3 (OR 0.65; 95% CI, 0.45-0.93; P for trend = 0.02), but positively associated with 16:1n-7 (OR 2.14; 95% CI, 1.46-3.12; P for trend < 0.001). The associations remained pronounced after multiple adjustments and in further stratified analyses.In distinguishing hypertensive patients and normotensive persons, 22:6n-3 was considered as an important n-3 FA. Increased serum proportion of 22:6n-3 was associated with decreased odds of newly diagnosed hypertension, which suggests that high levels of 22:6n-3 in serum or perhaps in diet may be beneficial for prevention of hypertension in the Chinese population.
The emerging alliance of sphingosine‐1‐phosphate signalling and immune cells: from basic mechanisms to implications in hypertension

Nicholas Don‐Doncow,Yun Zhang,Hana Matuskova,Anja Meissner

DOI: https://doi.org/10.1111/bph.14381

IF: 7.3

2018-07-03

British Journal of Pharmacology

Abstract:The immune system plays a considerable role in hypertension. In particular, T-lymphocytes are recognized as important players in its pathogenesis. Despite substantial experimental efforts, the molecular mechanisms underlying the nature of T-cell activation contributing to an onset of hypertension or disease perpetuation are still elusive. Amongst other cell types, lymphocytes express distinct profiles of GPCRs for sphingosine-1-phosphate (S1P) - a bioactive phospholipid that is involved in many critical cell processes and most importantly majorly regulates T-cell development, lymphocyte recirculation, tissue-homing patterns and chemotactic responses. Recent findings have revealed a key role for S1P chemotaxis and T-cell mobilization for the onset of experimental hypertension, and elevated circulating S1P levels have been linked to several inflammation-associated diseases including hypertension in patients. In this article, we review the recent progress towards understanding how S1P and its receptors regulate immune cell trafficking and function and its potential relevance for the pathophysiology of hypertension. LINKED ARTICLES: This article is part of a themed section on Immune Targets in Hypertension. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.12/issuetoc.

pharmacology & pharmacy
HDL Particle Subspecies and Their Association With Incident Type 2 Diabetes: The PREVEND Study

Sara Sokooti,Jose L Flores-Guerrero,Lyanne M Kieneker,Hiddo J L Heerspink,Margery A Connelly,Stephan J L Bakker,Robin P F Dullaart

DOI: https://doi.org/10.1210/clinem/dgab075

2021-02-10

Abstract:Abstract Context High-density lipoproteins (HDL) may be protective against type 2 diabetes (T2D) development, but HDL particles vary in size and function, which could lead to differential associations with incident T2D. A newly developed nuclear magnetic resonance (NMR)-derived algorithm provides concentrations for 7 HDL subspecies. Objective We aimed to investigate the association of HDL particle subspecies with incident T2D in the general population. Methods Among 4828 subjects of the Prevention of Renal and Vascular End-Stage Disease (PREVEND) study without T2D at baseline, HDL subspecies with increasing size from H1P to H7P were measured by NMR (LP4 algorithm of the Vantera NMR platform). Results A total of 265 individuals developed T2D (median follow-up of 7.3 years). In Cox regression models, HDL size and H4P (hazard ratio [HR] per 1 SD increase 0.83 [95% CI, 0.69-0.99] and 0.85 [95% CI, 0.75-0.95], respectively) were inversely associated with incident T2D, after adjustment for relevant covariates. In contrast, levels of H2P were positively associated with incident T2D (HR 1.15 [95% CI, 1.01-1.32]). In secondary analyses, associations with large HDL particles and H6P were modified by body mass index (BMI) in such a way that they were particularly associated with a lower risk of incident T2D, in subjects with BMI < 30 kg/m2. Conclusion Greater HDL size and lower levels of H4P were associated with a lower risk, whereas higher levels of H2P were associated with a higher risk of developing T2D. In addition, large HDL particles and H6P were inversely associated with T2D in nonobese subjects.
Immunological insights into hypertension: unraveling triggers and potential therapeutic avenues

Brandon G. Shokoples,Pierre Paradis,Ernesto L. Schiffrin

DOI: https://doi.org/10.1038/s41440-024-01731-6

2024-05-23

Hypertension Research

Abstract:Hypertension remains the leading cause of morbidity and mortality worldwide. Despite its prevalence, the development of novel antihypertensive therapies has only recently accelerated, with novel agents not yet commercialized, leaving a substantial proportion of individuals resistant to existing treatments. The intricate pathophysiology of hypertension is now understood to involve chronic low-grade inflammation, which places the immune system in the spotlight as a potential target for new therapeutics. This review explores the factors that initiate and sustain an immune response in hypertension, offering insights into potential targets for new treatments. Several factors contribute to immune activation in hypertension, including diet and damage-associated molecular pattern (DAMP) generation. Diets rich in fat or sodium can promote inflammation by inducing intestinal barrier dysfunction and triggering salt-sensitive receptors in T cells and dendritic cells. DAMPs, such as extracellular adenosine triphosphate and heat-shock protein 70, are released during episodes of increased blood pressure, contributing to immune cell activation and inflammation. Unconventional innate-like γδ T cells contribute to initiating and maintaining an immune response through their potential involvement in antigen presentation and regulating cytokine-mediated responses. Immunologic memory, sustained through the formation of effector memory T cells after exposure to hypertensive insults, likely contributes to maintaining an immune response in hypertension. When exposed to hypertensive insults, these memory cells are rapidly activated and contribute to elevated blood pressure and end-organ damage. Evidence from human hypertension, although limited, supports the relevance of distinct immune pathways in hypertension, and highlights the potential of targeted immune interventions in human hypertension.

peripheral vascular disease
Emerging topics on basic research in hypertension: interorgan communication and the need for interresearcher collaboration

Keisuke Shinohara

DOI: https://doi.org/10.1038/s41440-023-01176-3

2023-01-17

Hypertension Research

Abstract:The pathogenesis of hypertension is multifactorial and highly complex. Basic research plays critical roles in elucidating the complex pathogenesis of hypertension and developing its treatment. This review covers recent topics in basic research related to hypertension in the following six parts: brain/autonomic nervous system, kidney, vascular system, potential treatments, extracellular vesicles, and gut microbiota. The brain receives afferent nerve inputs from peripheral organs, including the heart, kidneys, and adipose tissue, and humoral inputs from circulating factors such as proinflammatory cytokines and leptin, which are involved in the regulation of central sympathetic outflow. In the kidneys, changes in Wnt/β-catenin signaling have been reported in several hypertensive models. New findings on the renin-angiotensin-aldosterone system in the kidneys have also been reported. Sirtuin 6, which participates in various cellular functions, including DNA repair, has been shown to have protective effects on the vascular system. Skin water conservation, mediated by skin vasoconstriction and the accumulation of osmolytes such as sodium, has been found to contribute to hypertension. Studies of rivaroxaban and sodium-glucose cotransporter-2 inhibitors as drug repositioning candidates have been performed. Extracellular vesicles have been shown to be involved in novel diagnostic approaches and treatments for hypertension as well as other diseases. In gut microbiota studies, interactions between microbiota and antihypertensive drugs and potential pathophysiology linking microbiota and COVID-19 have been reported. It can be seen that inter-organ communication has received particular attention from these recent research topics. To truly understand the pathogenesis of hypertension and to develop treatments for conquering hypertension, interresearcher communication and collaboration should be further facilitated.

peripheral vascular disease
Detailed cross-sectional association between traditional risk factors and high systolic blood pressure in a Japanese population

Michihiro Satoh,Takahisa Murakami,Hirohito Metoki

DOI: https://doi.org/10.1038/s41440-024-01639-1

2024-03-12

Hypertension Research

Abstract:Hypertension Research, Published online: 11 March 2024; doi:10.1038/s41440-024-01639-1 Detailed cross-sectional association between traditional risk factors and high systolic blood pressure in a Japanese population

peripheral vascular disease
Associations of metabolic disorders with hypertension and cardiovascular disease: recent findings and therapeutic perspectives

Atsushi Tanaka,Koichi Node

DOI: https://doi.org/10.1038/s41440-024-01737-0

2024-05-30

Hypertension Research

Abstract:We theoretically know that metabolic disorders, including overweight/obesity, insulin resistance, diabetes, dyslipidemia, and relevant tissue/organ damage, play a critical role in elevating blood pressure and developing hypertension. However, staying abreast of the ever-evolving and current research on the various metabolic disorder topics is difficult. At the same time, as hypertension in childhood and adolescence is attracting significant attention globally, it is becoming increasingly evident that metabolic disorders exert an important role in its pathogenesis. In order to effectively prevent hypertension, it is essential to appropriately approach metabolic disorders, and importantly, this approach must be practiced continuously throughout all generations. Thus, focusing on metabolic disorders is the first and essential step in effectively managing and preventing hypertension. In this Mini-Review, we introduce cutting-edge research findings on "Metabolism," published in 2023 by Hypertension Research, and discuss relevant topics and therapeutic and future perspectives.

peripheral vascular disease
Differences in HDL-related mortality risk between individuals with and without hypertension: a prospective cohort study in UK Biobank

Jun-Xiang Chen,Rui Li,Tingting Geng,Yuexuan Wang,Qi Lu,Zhou-Zheng Tu,Yue Li,Yun-Fei Liao,Kun Yang,Wen-Wei Tong,Yan-Feng Zhou,Gang Liu,An Pan,Li-Rong Zhou

DOI: https://doi.org/10.1093/eurjpc/zwad053

IF: 8.526

2023-02-21

European Journal of Preventive Cardiology

Abstract:Abstract Background and aims Very high levels of high-density lipoprotein cholesterol (HDL-C) have been paradoxically linked to increased mortality risk. The present study aimed to examine associations of HDL-C and varied sizes of the HDL particle (HDL-P) with mortality risk stratified by hypertension. Methods and results This prospective cohort study included 429 792 participants (244 866 with hypertension and 184 926 without hypertension) from the UK Biobank. During a median follow-up of 12.7 years, 23 993 (9.8%) and 8142 (4.4%) deaths occurred among individuals with and without hypertension, respectively. A U-shaped association of HDL-C with all-cause mortality was observed in individuals with hypertension after multivariable adjustment, whereas an L-shape was observed in individuals without hypertension. Compared with individuals with normal HDL-C of 50–70 mg/dL, those with very high HDL-C levels (>90 mg/dL) had a significantly higher risk of all-cause mortality among individuals with hypertension (hazard ratio, 1.47; 95% confidence interval, 1.35–1.61), but not among those without hypertension (1.05, 0.91–1.22). As for HDL-P, among individuals with hypertension, a larger size of HDL-P was positively whereas smaller HDL-P was negatively associated with all-cause mortality. After additional adjustment for larger HDL-P in the model, the U-shaped association between HDL-C and mortality risk was altered to an L-shape among individuals with hypertension. Conclusions The increased risk of mortality associated with very high HDL-C existed only in individuals with hypertension, but not in those without hypertension. Moreover, the increased risk at high HDL-C levels in hypertension was likely driven by larger HDL-P.

cardiac & cardiovascular systems
Homocysteine, hyperhomocysteinemia, and H-type hypertension

Dong-Feng Wu,Rui-Xing Yin,Jin-Long Deng

DOI: https://doi.org/10.1093/eurjpc/zwae022

IF: 8.526

2024-01-17

European Journal of Preventive Cardiology

Abstract:Abstract Homocysteine (Hcy) is a sulphur-containing nonessential amino acid derived from the intermediate metabolites of methionine. Methionine is obtained from dietary proteins, such as poultry, meat, eggs, seafood, and dairy products. Abnormalities in Hcy metabolic pathways, deficiencies in dietary methionine, folate, and vitamins B12, B6, and B2 and genetic defects, polymorphisms, or mutations in Hcy metabolism-related enzymes may lead to an increase in plasma Hcy levels. Generally, a plasma Hcy level higher than 10 or 15 μmol/L has been defined as hyperhomocysteinemia (HHcy). An individual with essential hypertension complicated with HHcy is considered to have H-type hypertension (HTH). Currently, HHcy is considered a novel independent risk factor for various cardiovascular diseases. To provide a useful reference for clinicians, the research progress on Hcy, HHcy, and HTH in recent years was systematically reviewed here, with a focus on the source and metabolic pathways of Hcy, plasma Hcy levels and influencing factors, detection methods for plasma Hcy levels, relationship between Hcy concentration and hypertension, pathogenesis of HTH, cardiovascular complications of HTH, and treatment of HTH.

cardiac & cardiovascular systems
Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population

Takeshi Fujiwara,Yuichiro Yano,Satoshi Hoshide,Hiroshi Kanegae,Kazuomi Kario

DOI: https://doi.org/10.1001/jamacardio.2018.1233

2018-07-01

JAMA Cardiology

Abstract:Importance: The clinical outcomes associated with masked hypertension defined by home blood pressure monitoring (HBPM) in clinical settings remain uncertain.Objective: To assess the association between masked hypertension and cardiovascular disease events in clinical settings.Design, Setting, and Participants: This observational cohort study used data from 4261 outpatients treated at 71 primary practices or university hospitals throughout Japan who were enrolled in the Japan Morning Surge-Home Blood Pressure study between January 1, 2005, and December 31, 2012. Participants had a history of or risk factors for cardiovascular disease and were followed up through March 31, 2015. Participants underwent clinic blood pressure (BP) measurements on 2 occasions as well as HBPM measurements in the morning and evening for a 14-day period. Urine albumin to creatinine ratio and circulating brain (or B-type) natriuretic peptide levels were quantified at baseline as a marker of cardiovascular end-organ damage. Data were analyzed from July 1, 2017, to October 31, 2017.Exposures: Participants were categorized into 4 BP groups: (1) masked hypertension-hypertensive home BP levels (systolic, ≥135 mm Hg; diastolic, ≥85 mm Hg) and nonhypertensive clinic BP levels (systolic, <140 mm Hg; diastolic, <90 mm Hg); (2) white-coat hypertension-nonhypertensive home BP levels (systolic, <135 mm Hg; diastolic, <85 mm Hg) and hypertensive clinic BP levels (systolic, ≥140 mm Hg; diastolic, ≥90 mm Hg); (3) sustained hypertension-hypertensive home and clinic BP levels; and (4) controlled BP-nonhypertensive home and clinic BP levels.Main Outcomes and Measures: Incident stroke and coronary heart disease.Results: Of the 4261 participants, 2266 (53.2%) were women, 3374 (79.2%) were taking antihypertensive medication, and the mean (SD) age was 64.9 (10.9) years. During a median (interquartile range) follow-up of 3.9 (2.4-4.6) years, 74 stroke (4.4 per 1000 person-years) and 77 coronary heart disease (4.6 per 1000 person-years) events occurred. The masked hypertension group had a greater risk for stroke compared with the controlled BP group (hazard ratio, 2.77; 95% CI, 1.20-6.37), independent of traditional cardiovascular risk factors, urine albumin to creatinine ratio, and circulating B-type natriuretic peptide levels. Conversely, masked hypertension yielded no association with coronary heart disease risk.Conclusions and Relevance: In the Japanese general practice population, masked hypertension defined by HBPM may be associated with an increased risk for stroke events. Use of HBPM may improve the assessment of BP-related risks and identify new therapeutic interventions aimed at preventing cardiovascular disease events.

medicine, general & internal
High-Density Lipoprotein and Heart Failure

Liyun Xing,Yixuan Liu,Jiayu Wang,Peiqing Tian,Ping Liu

DOI: https://doi.org/10.31083/j.rcm2411321

2023-11-21

Abstract:The protective effect of high-density lipoprotein (HDL) on atherosclerosis is well known, and its mechanisms of action has been extensively studied. However, the impact of HDL on heart failure and its mechanisms are still controversial or unknown. The cardioprotective role of HDL may be reflected in its antioxidant, anti-inflammatory, anti-apoptotic, and endothelial function protection. In epidemiological studies, high-density lipoprotein cholesterol (HDL-C) levels have been negatively associated with heart failure (HF). The major protein component of HDL-C is apolipoprotein (Apo) A-I, while paraoxonase-1 (PON-1) is an essential mediator for many protective functions of HDL, and HDL may act through components like (Apo) A-I or PON-1 to delay heart failure progress. HDL can slow heart failure disease progression through parts like (Apo) A-I or PON-1. The potential causality between HDL and heart failure, the role of HDL in the pathogenesis of HF, and its interaction with C-reactive protein (CRP), triglycerides (TG), and monocytes in the process of heart failure have been briefly summarized and discussed in this article. HDL plays an important role in the pathogenesis, progression and treatment of HF.
The association between HDL-C and stroke in people over 40 years of age: A NHANES cross-sectional study

Kevin Patel

DOI: https://doi.org/10.1101/2024.04.07.24305464

2024-04-11

MedRxiv

Abstract:Background: Previously, studies have indicated that high-density cholesterol (HDL-C) levels are associated with lower risk of cardiovascular disease. However, this has been challenged in recent years. Method: This cross-sectional study was conducted on data from the National Health and Nutrition Examination Survey 2011-2020. There were total of 15232 out of 45462 individuals who were age >40 years old, not missing HDL-C levels and not missing stroke data. The independent variable was HDL-Cholesterol. The outcome variable was stroke. We used multivariate logistic regression models to assess the relationship between stroke and HDL-C in three models consisting of the following explanatory variables: 1. HDL-C alone (unadjusted model), 2. HDL-C and non-modifiable risk factors (age, sex and race), 3. HDL-C, non-modifiable, and modifiable risk factors [hypertension, diabetes and smoking status] risk factors. We also conducted analyses stratified by sex and race. Results: HDL-C categories 40-59 mg/dl (unadjusted model- 0.759, CI: 0.639, 0.901; non-modifiable risk factors adjusted- 0.668, CI: 0.558, 0.798) and 60-79 mg/dl (unadjusted model- 0.733, CI: 0.598, 0.898; non-modifiable risk factors adjusted- 0.565, CI: 0.455, 0.701) had significantly lower risk of stroke relative to HDL-C category <40 mg/dl. But when adjusted for modifiable risk factors, risk of stroke HDL-C categories 40-59 mg/dl and 60-79 mg/dl categories were not significantly different from the HDL-C 90 mg/dl categories were not significantly different from the HDL-C <40 mg/dl category in all models. In stratified analyses, HDL-C was significantly inversely associated with the risk of stroke in male gender and in non-Hispanic White race. Conclusion: Our study reveals various inverse relationship between HDL-C and risk of stroke. These findings suggest that relevant levels of HDL-C may be beneficial in preventing stroke in the absence of modifiable risk-factors.
Gut bacteria-derived extracellular vesicles and hypertension

Kento Kitada

DOI: https://doi.org/10.1038/s41440-024-01712-9

2024-05-21

Hypertension Research

Abstract:Hypertension Research, Published online: 20 May 2024; doi:10.1038/s41440-024-01712-9 Gut bacteria-derived extracellular vesicles and hypertension

peripheral vascular disease

A fascinating association between HDL as a multi-potent particle and hypertension

Intriguing review and topics in this month of Hypertension Research

The causal relationship between non-alcoholic fatty liver disease, hypertension, and cardiovascular diseases: implications for future research

Sex and age difference in associations between anthropometric indices and hypertension

Pulse pressure amplification as a hemodynamic predictor of cardiovascular disease

Bridging the Gap Between the Bench and Bedside: Clinical Applications of High-density Lipoprotein Function

Original article and review highlighted in this month of Hypertension Research

Combining muscle strengthening activity and aerobic exercise: a prescription for better health in patients with hypertension

Inverse Association of Serum Docosahexaenoic Acid With Newly Diagnosed Hypertension: A Community-based Case-control Study.

The emerging alliance of sphingosine‐1‐phosphate signalling and immune cells: from basic mechanisms to implications in hypertension

HDL Particle Subspecies and Their Association With Incident Type 2 Diabetes: The PREVEND Study

Immunological insights into hypertension: unraveling triggers and potential therapeutic avenues

Emerging topics on basic research in hypertension: interorgan communication and the need for interresearcher collaboration

Detailed cross-sectional association between traditional risk factors and high systolic blood pressure in a Japanese population

Associations of metabolic disorders with hypertension and cardiovascular disease: recent findings and therapeutic perspectives

Differences in HDL-related mortality risk between individuals with and without hypertension: a prospective cohort study in UK Biobank

Homocysteine, hyperhomocysteinemia, and H-type hypertension

Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population

High-Density Lipoprotein and Heart Failure

The association between HDL-C and stroke in people over 40 years of age: A NHANES cross-sectional study

Gut bacteria-derived extracellular vesicles and hypertension